Zions Leads Varex Refinancing As Valuation And Fee Potential Draw Focus
Zions Bancorporation NA ZION | 58.83 | -0.25% |
- Zions Bancorporation National Association acted as lead arranger and bookrunner on Varex Imaging Corporation's new $490 million Credit and Guaranty Agreement.
- The bank will also serve as administrative and collateral agent for the syndicated credit facility.
- The transaction highlights Zions' role in complex corporate lending and syndicated loan coordination.
Zions Bancorporation (NasdaqGS:ZION) is drawing attention for its role in a sizeable $490 million credit refinancing for Varex Imaging, at a time when its shares trade around $53.54. The stock shows mixed recent performance, with a 4.0% decline over the past week and a 12.6% decline over the past month, but a 13.2% gain over the past year and a very large 3 year return. This corporate banking mandate adds another data point for investors tracking how the bank deploys its balance sheet and fee generating capabilities.
Acting as lead arranger, bookrunner, and agent on a complex facility may present opportunities for Zions to deepen relationships and potentially cross sell other services over time. Investors watching NasdaqGS:ZION can consider how recurring roles in syndicated loans might relate to fee income stability and client mix, alongside the share price record over 1, 3 and 5 years.
Stay updated on the most important news stories for Zions Bancorporation National Association by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Zions Bancorporation National Association.
Quick Assessment
- ✅ Price vs Analyst Target: At US$53.54, Zions trades about 24% below the US$66.50 analyst price target.
- ✅ Simply Wall St Valuation: Simply Wall St flags the shares as undervalued, trading around 59.3% below its estimated fair value.
- ❌ Recent Momentum: The 30 day return is a 12.6% decline, so short term momentum is weak.
There is only one way to know the right time to buy, sell or hold Zions Bancorporation National Association. Head to Simply Wall St's company report for the latest analysis of Zions Bancorporation National Association's Fair Value.
Key Considerations
- 📊 The Varex Imaging refinancing shows Zions winning lead roles on large syndicated facilities, which can support fee based income and client visibility.
- 📊 Watch how often Zions appears as lead arranger on similar deals, alongside its P/E of 9.0 versus the banks industry average of about 11.2.
- ⚠️ The flagged risk is significant insider selling over the past 3 months, so compare that activity with any reaction to this new mandate.
Dig Deeper
For the full picture including more risks and rewards, check out the complete Zions Bancorporation National Association analysis. Alternatively, you can check out the community page for Zions Bancorporation National Association to see how other investors believe this latest news will impact the company's narrative.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
